MX2019000600A - Agente estimulador del receptor 5-hidroxitriptamina 1b para reparación de piel y/o cabello. - Google Patents
Agente estimulador del receptor 5-hidroxitriptamina 1b para reparación de piel y/o cabello.Info
- Publication number
- MX2019000600A MX2019000600A MX2019000600A MX2019000600A MX2019000600A MX 2019000600 A MX2019000600 A MX 2019000600A MX 2019000600 A MX2019000600 A MX 2019000600A MX 2019000600 A MX2019000600 A MX 2019000600A MX 2019000600 A MX2019000600 A MX 2019000600A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- hydroxytryptamine
- receptor
- hair repair
- stimulating agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/884—Sequential application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
La presente invencion se refiere al campo de la reparacion de la piel y/o del cabello, con fines terapeuticos y cosmeticos; mas especificamente, se refiere a un agente que estimula el receptor de 5-hidroxitriptamina 1B, para usarse en el refuerzo de la reparacion de la piel y/o del cabello.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2016001136 | 2016-07-15 | ||
PCT/EP2017/067791 WO2018011382A1 (en) | 2016-07-15 | 2017-07-13 | 5-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repair |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019000600A true MX2019000600A (es) | 2019-06-13 |
Family
ID=56787641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019000600A MX2019000600A (es) | 2016-07-15 | 2017-07-13 | Agente estimulador del receptor 5-hidroxitriptamina 1b para reparación de piel y/o cabello. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20190290641A1 (es) |
EP (1) | EP3484462B1 (es) |
JP (1) | JP2019524723A (es) |
KR (1) | KR20190038840A (es) |
CN (1) | CN110022869A (es) |
AU (1) | AU2017295038B2 (es) |
BR (1) | BR112019000706A8 (es) |
CA (1) | CA3030054A1 (es) |
MX (1) | MX2019000600A (es) |
WO (1) | WO2018011382A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108348486A (zh) | 2015-07-17 | 2018-07-31 | 巴斯德研究院 | 用作卫星细胞自我更新和/或分化的启动子的5-羟色胺1b受体激动剂 |
US11013830B2 (en) | 2015-11-20 | 2021-05-25 | Institut Pasteur | 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential |
MX2020014286A (es) * | 2018-06-20 | 2021-03-25 | Lts Lohmann Therapie Systeme Ag | Sistema terapeutico transdermico que contiene asenapina. |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63203625A (ja) | 1987-02-19 | 1988-08-23 | Kao Corp | 5α−リダクタ−ゼ阻害剤 |
FR2739553B1 (fr) | 1995-10-06 | 1998-01-02 | Oreal | Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute |
FR2758263B1 (fr) * | 1997-01-16 | 1999-12-17 | Oreal | Utilisation d'un antagoniste ou d'un agoniste de serotonine specifiques respectivement du recepteur 5ht2 et 5ht1d dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue |
FR2778558B1 (fr) | 1998-05-12 | 2001-02-16 | Oreal | Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute |
ES2147538B1 (es) | 1999-01-29 | 2001-04-01 | Revlon Consumer Prod Corp | Una locion capilar con propiedades mejoradas en su accion protectora del cabello y preventiva de su caida, y de reduccion de los efectos externos de la alopecia androgenetica y con ello de la caida del cabello. |
JP3441665B2 (ja) | 1999-02-04 | 2003-09-02 | 株式会社資生堂 | (2−置換オキシフェニル)アルカンアミド誘導体及び養毛剤、皮膚外用剤 |
US20060052405A1 (en) | 2000-07-19 | 2006-03-09 | Knowles W R | Hair loss prevention |
FR2812192B1 (fr) | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
ATE316387T1 (de) * | 2000-09-22 | 2006-02-15 | Perlei Medical Produkte Gmbh | Verwendung von antifibrinolytika für die präparation und herstellung von tupfern, kompressen oder pflaster |
ATE337009T1 (de) | 2001-05-31 | 2006-09-15 | Pfizer Prod Inc | Medizinische verwendung thyromimetischer verbindungen gegen haarausfall und zusammensetzungen |
WO2003041669A1 (en) | 2001-09-28 | 2003-05-22 | Lg Household & Health Care Ltd. | A composition for promoting hair growth |
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
US6860042B2 (en) | 2002-07-19 | 2005-03-01 | Walker-Dawson Interests, Inc. | Excavation system employing a jet pump |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
AU2003274569B2 (en) | 2002-11-12 | 2008-07-31 | Warner-Lambert Company Llc | Method of stimulating hair growth using benzopyrans |
CA2511089A1 (en) | 2003-01-17 | 2004-08-05 | Warner-Lambert Company Llc | Androgen receptor antagonists |
OA13170A (en) | 2003-05-22 | 2006-12-13 | Pharmacia Italia Spa | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors. |
US20050118282A1 (en) | 2003-09-16 | 2005-06-02 | Aphios Corporation | Compositions and methods for inhibiting 5-alpha reductase |
AR041407A1 (es) | 2003-09-26 | 2005-05-18 | Nestor Alberto Kerner | Oligonucleotidos antiandrogenos utilizables en el tratamiento de patologias dermatologicas relacionadas con el metabolismo de los androgenos, sus composiciones farmaceuticas y sus usos y metodos de tratamiento |
US20060009430A1 (en) | 2004-07-01 | 2006-01-12 | Kelly Gregory J | Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone |
WO2006006065A1 (en) | 2004-07-08 | 2006-01-19 | Warner-Lambert Company Llc | Androgen modulators |
DE202006007482U1 (de) | 2006-05-10 | 2006-07-20 | Sentner, Thomas | Leuchtmöbel |
BRPI0713425A2 (pt) * | 2006-06-16 | 2012-03-13 | H. Lundbeck A/S | composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto |
US9221779B2 (en) * | 2006-06-22 | 2015-12-29 | Ramot At Tel-Aviv University Ltd. | Serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
FR2903984B1 (fr) | 2006-07-24 | 2008-10-03 | Genfit Sa | Derives d'imidazolones substitues, preparation et utilisations |
WO2008084286A2 (en) * | 2006-10-25 | 2008-07-17 | Arterial Remodeling Technologies, S.A. | Method for expansion and deployment of polymeric structures including stents |
US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
ITTO20060918A1 (it) * | 2006-12-22 | 2008-06-23 | Chiara Cesano | Composizione cosmetica e farmaceutica e mezzo di coltura per la rigenerazione del tessuto cutaneo, e relativi usi |
WO2008078353A1 (en) * | 2006-12-22 | 2008-07-03 | Medestea Internazionale S.P.A. | A novel use of antidepressant compounds and related compositions |
US8680134B2 (en) * | 2009-10-23 | 2014-03-25 | Avi Dascalu | Triptans for the treatment of psoriasis |
AU2011269989B2 (en) | 2010-06-23 | 2014-12-11 | Hanmi Science Co., Ltd. | Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
AU2013305563B2 (en) * | 2012-08-24 | 2018-09-27 | Integurx Therapeutics, Llc | Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents |
US20160101093A1 (en) * | 2013-05-21 | 2016-04-14 | Jason B. Wynberg | Methods for the treatment of premature ejaculation |
US9399039B1 (en) * | 2015-06-30 | 2016-07-26 | University Of South Florida | Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use |
-
2017
- 2017-07-13 CA CA3030054A patent/CA3030054A1/en active Pending
- 2017-07-13 WO PCT/EP2017/067791 patent/WO2018011382A1/en unknown
- 2017-07-13 AU AU2017295038A patent/AU2017295038B2/en not_active Expired - Fee Related
- 2017-07-13 MX MX2019000600A patent/MX2019000600A/es unknown
- 2017-07-13 JP JP2019501427A patent/JP2019524723A/ja active Pending
- 2017-07-13 CN CN201780055993.4A patent/CN110022869A/zh active Pending
- 2017-07-13 KR KR1020197004019A patent/KR20190038840A/ko not_active Application Discontinuation
- 2017-07-13 EP EP17742997.4A patent/EP3484462B1/en active Active
- 2017-07-13 BR BR112019000706A patent/BR112019000706A8/pt unknown
- 2017-07-13 US US16/316,557 patent/US20190290641A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2019524723A (ja) | 2019-09-05 |
US20190290641A1 (en) | 2019-09-26 |
WO2018011382A1 (en) | 2018-01-18 |
CA3030054A1 (en) | 2018-01-18 |
EP3484462B1 (en) | 2022-12-14 |
BR112019000706A8 (pt) | 2022-12-06 |
KR20190038840A (ko) | 2019-04-09 |
AU2017295038A1 (en) | 2019-01-24 |
EP3484462A1 (en) | 2019-05-22 |
CN110022869A (zh) | 2019-07-16 |
BR112019000706A2 (pt) | 2019-05-07 |
AU2017295038B2 (en) | 2022-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122603T1 (el) | Γαμμα-δικετονες για τη θεραπευτικη αντιμετωπιση και την προληψη της γηρανσης του δερματος και των ρυτιδων | |
EA202091134A1 (ru) | Экзосомы для иммуноонкологической и противовоспалительной терапии | |
PH12018502429A1 (en) | Antibody molecules for cancer treatment | |
CY1124595T1 (el) | Ρυθμιση δραστικοτητας συμπληρωματος | |
MX2021013837A (es) | Enfoque de inmunoterapias de combinacion para el tratamiento del cancer. | |
TWD170518S (zh) | 美容器具 | |
MX2017013562A (es) | Reguladores de microbioma y usos relacionados de los mismos. | |
WO2017134302A3 (en) | Targeted therapeutic agents and uses thereof | |
MX2018008426A (es) | Combinaciones anti-egfr para tratar tumores. | |
BR112018003269A2 (pt) | conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização | |
GEP20217317B (en) | Combination therapy for the treatment of cancer | |
MX2015011296A (es) | Dispositivo foto-terapeutico, metodo y uso. | |
MX2022014277A (es) | Metodos para una mejor administracion de agentes activos a tumores. | |
EA201991997A1 (ru) | Комбинированная терапия | |
CA189459S (en) | Cosmetic skin treatment apparatus | |
MX2020003762A (es) | Composiciones cosmeticas y metodo para tratar la piel. | |
CY1122818T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου | |
NZ773981A (en) | Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat | |
MX2018008645A (es) | Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. | |
IL257670A (en) | Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer | |
PH12020500029A1 (en) | Cosmetic compositions and methods of use | |
GB2582683B (en) | Composition for the care of human hair | |
MX2018008643A (es) | Derivados de 3-((hetero)aril)-8-amino-2-oxo-1,3-diaza-espiro-[4.5] -decano. | |
MX2019000600A (es) | Agente estimulador del receptor 5-hidroxitriptamina 1b para reparación de piel y/o cabello. | |
EA201792560A1 (ru) | Наночастицы для применения в качестве терапевтической вакцины |